163 related articles for article (PubMed ID: 8392699)
1. ADP-dependence of platelet activation induced by a thrombin receptor agonist.
Savi P; Dol F; Herbert JM
Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):115-9. PubMed ID: 8392699
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
3. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
4. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
Steen VM; Holmsen H; Aarbakke G
Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557
[TBL] [Abstract][Full Text] [Related]
5. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.
Connolly TM; Condra C; Feng DM; Cook JJ; Stranieri MT; Reilly CF; Nutt RF; Gould RJ
Thromb Haemost; 1994 Oct; 72(4):627-33. PubMed ID: 7878643
[TBL] [Abstract][Full Text] [Related]
6. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
7. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
[TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease.
Kinlough-Rathbone RL; Perry DW; Packham MA
Thromb Haemost; 1995 Jan; 73(1):122-5. PubMed ID: 7740483
[TBL] [Abstract][Full Text] [Related]
9. Reassessment of the evidence for the role of secreted ADP in biphasic platelet aggregation. Mechanism of inhibition by creatine phosphate plus creatine phosphokinase.
Huang EM; Detwiler TC
J Lab Clin Med; 1980 Jan; 95(1):59-68. PubMed ID: 7350241
[TBL] [Abstract][Full Text] [Related]
10. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
[TBL] [Abstract][Full Text] [Related]
11. Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin.
Kinlough-Rathbone RL; Perry DW; Guccione MA; Rand ML; Packham MA
Thromb Haemost; 1993 Dec; 70(6):1019-23. PubMed ID: 8165594
[TBL] [Abstract][Full Text] [Related]
12. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
McNicol A; Robson CA
J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
Packham MA; Mustard JF
Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
[TBL] [Abstract][Full Text] [Related]
14. Role of intracellular signaling events in ADP-induced platelet aggregation.
Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of U46619 induced human platelet aggregation by aspirin.
Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
[TBL] [Abstract][Full Text] [Related]
16. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
17. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
18. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans.
Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M
Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist.
Ma L; Hollenberg MD; Wallace JL
Br J Pharmacol; 2001 Oct; 134(4):701-4. PubMed ID: 11606309
[TBL] [Abstract][Full Text] [Related]
20. Requirement for thrombin receptor occupancy during platelet secretion under aggregating and non-aggregating conditions.
Koike K; Holmsen H
Thromb Haemost; 1987 Dec; 58(4):1053-9. PubMed ID: 2832963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
